Narcolepsy genetic marker HLA DQB1*06:02 and excessive daytime sleepiness in Parkinson disease patients treated with dopaminergic agents
ConclusionPD individuals are more likely to experience EDS and fall asleep inappropriately during activities if DQB1*0602 positive. Genetic vulnerability may explain EDS risk in PD.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Brain | Dementia | Genetics | Narcolepsy | Neurology | Parkinson's Disease | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study